Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia

2026/07/28 by Lubna Osman‐Kardash, Ahmed Alnajar, Anthony D. Anderson +21
Medicine · #Acute Lymphoblastic Leukemia research #Chronic Lymphocytic Leukemia Research #Chronic Myeloid Leukemia Treatments

paper · doi:10.1002/ajh.70452

openalex publication_date 2026/07/28 · openalex created_date 2026/07/29 · openalex updated_date 2026/07/30

Citations

• Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation
• Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy